CDW Corp (CDW) Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 net sales rose 3.3% year-over-year to $5.186B, while gross margin fell 70 bps to 22.3% and GAAP EPS declined 9.8% to $1.97; non-GAAP EPS was $2.48, down 3.7% .
- Sequentially vs Q3, Q4 showed higher gross margin (22.3% vs 21.8%) but lower operating income ($408.6M vs $481.6M) and lower non-GAAP EPS ($2.48 vs $2.63) as client devices and pricing mix compressed product margins .
- Public segment strength (Healthcare +27.5% YoY; Public +4.4%) offset declines in Government (-7.1%) and Education (-3.7%); Corporate (+2.6%) and Small Business (+2.7%) posted modest YoY growth .
- 2025 outlook: CDW targets exceeding US IT growth by 200–300 bps with low single-digit gross profit and non-GAAP EPS growth; Q1 is guided to low single-digit EPS growth YoY and gross profit similar to 2024 levels; Board increased buyback authorization by $750M and set quarterly dividend at $0.625 .
What Went Well and What Went Wrong
What Went Well
- Public segment resilience led by Healthcare: “Healthcare was a standout… up 30%,” reflecting investments in cloud, security, and managed services; cloud profit up mid-teens and services top-line +10% with double-digit profit growth .
- Gross margin durability: Q4 gross margin reached the highest quarterly level of 2024 (22.3%), supported by netted-down revenue (cloud/SaaS) comprising 35.8% of gross profit .
- Capital allocation: Returned $832M to shareholders in 2024 (dividends $332M; buybacks $500M); added $750M repurchase authorization and maintained dividend growth (annual dividend ~25% payout target) .
What Went Wrong
- Margin rate and mix headwinds: Year-over-year gross margin fell to 22.3% due to higher mix of notebooks/desktop and modest rate contraction across product categories; GAAP EPS fell 9.8% YoY .
- Government and Education softness: Government -7.1% and Education -3.7% YoY driven by federal uncertainty and K-12 funding normalization post-stimulus, partially offset by Healthcare strength .
- Pricing intensity/competition: Management cited “irrational pricing” and larger-deal lumpiness pressuring volume and margins; CDW maintained pricing discipline, walking away from uneconomic transactions .
Financial Results
Summary Financials (YoY and sequential context)
Segment Net Sales (Q4 detail)
KPIs and Operating Metrics
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “The team delivered a solid finish to a challenging year… consultative solutions strategy… is more vital than ever.”
- CFO: “Gross margin of 22.3%… highest margin quarter of the year… decline vs 23% last year due to higher notebooks/desktop mix and modest rate contraction.”
- CEO on Healthcare strategy: “Our deeply experienced Healthcare subject matter experts… solutions like our proprietary Patient Room Next AI and IoT-based solution…” .
- CFO on outlook: “We expect… IT market to grow low single digits… and target market outperformance of 200 to 300 basis points… non-GAAP EPS to grow low single digits.” .
- CEO on competition: “We are seeing deals at low margin… that is not our business model; we are not racing to the bottom.” .
Q&A Highlights
- Public verticals: Education and federal have puts/takes; CDW cautiously factoring policy/workforce impacts; expects tech to be a long-run winner .
- Mix and margin bridge: Slight compression in net sales from leaning into netted-down; expense pressure depresses non-GAAP OI; leverage improves at EPS level .
- Healthcare drivers: Balanced mix including some larger transactions; strength offset declines in Government/Education .
- Core margins outlook: Non-netted-down margins expected to hold firm in FY25 with services attach supporting hardware recovery .
- Mission Cloud: Profitable, strategic fit; limited near-term EPS accretion due to foregone interest; significant longer-term potential .
Estimates Context
- Wall Street consensus via S&P Global was not available during this session due to data access limits; therefore, we cannot provide versus-estimate comparisons for Q4 2024. If needed, we can refresh and add consensus EPS, revenue, and surprise metrics once access is restored.
Key Takeaways for Investors
- Q4 2024 showed stabilization in core commercial and hardware categories with strong Healthcare-led public performance, but YoY margin rate and EPS declined given client-device mix and pricing pressure .
- Structural mix shift toward cloud/SaaS and services remains a multi-year margin tailwind; netted-down contribution held at ~36% of gross profit in Q4 .
- 2025 setup: low single-digit growth in gross profit and non-GAAP EPS with stable margin, outpacing market by 200–300 bps; Q1 seasonally heavier SG&A ratio but EPS guided to low single-digit YoY growth .
- Capital return is a notable catalyst: $750M incremental buyback and steady dividend ($0.625 quarterly), supported by >$1B adjusted FCF and liquidity ($1.7B cash+revolver) .
- Watch federal/education demand normalization and continued competitive intensity; management is holding pricing discipline, which may trade off near-term volume for profitability integrity .
- Healthcare momentum and services attach should continue to offset areas of macro weakness; Mission Cloud expands AWS capabilities and managed services monetization .
- Sequentially, monitor client-device margin rate and DSO uptick (84 days) as working capital normalizes post Q4; CCC remains inside target range (18 days) .
Citations: .